Onconetix (ONCO) Proxy filing summary

Executive summary

• Special Meeting scheduled for April 30, 2026, to vote on a reverse stock split and potential adjournment to solicit more proxies if needed.

• Board seeks authority to effect one or more reverse stock splits at ratios between 1-for-2 and 1-for-10, not exceeding 1-for-100 in aggregate, within one year of approval.

• Reverse stock split aims to maintain Nasdaq listing compliance and improve stock price, liquidity, and marketability.

• Board unanimously recommends voting in favor of both proposals.

Voting matters and shareholder proposals

• Proposal 1: Grant Board authority to amend the Charter for one or more reverse stock splits at specified ratios.

• Proposal 2: Approve adjournment of the meeting if more time is needed to solicit proxies for Proposal 1.

• Both proposals require a majority of votes cast, assuming quorum is present.

• All proposals are considered routine, allowing brokers discretionary voting if no instructions are given.

Board of directors and corporate governance

• Board retains discretion to implement or abandon reverse stock splits if deemed not in the best interests of shareholders.

• Board's primary objective is to increase per-share trading price and maintain Nasdaq compliance.